🎯
LATEST VERIFIED AI EXECUTION
Our quantitative model captured a massive +5.61% net profit on $AUB.PA in just 163h 31m. Stop guessing, start executing.
$OCUL
Ocular Therapeutix Inc
UNITED STATESFREE PREVIEW
AVG HISTORICAL GAP-1.05%
MAX GAP RECORD-9.23%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
QUANTITATIVE LIVE RADAR BLOTTER
Institutional execution stream for $OCUL
EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
| Execution Date | Strategy & Setup | Direction | Execution Range | Hold Time | Exit Trigger | Net PnL |
|---|---|---|---|---|---|---|
| RADAR SCANNING: WAITING FOR NEXT CATALYST | ||||||
🔒 Institutional Data Protected
UNLOCK FULL BLOTTERExact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.
VOLATILITY & BIAS PROFILE
AVG VOLATILITY4.3%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA. Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL